Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Minimed GroupSTU:B8S 20 Receivables Turnover is 1.97 as of Apr. 2026. GuruFocus rates STU:B8S with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Minimed Group ranks worse than 73.89% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Minimed Group's Revenue for the
three
months ended in Apr. 2026 was €716 Mil. Minimed Group's average Accounts Receivable for the
three
months ended in Apr. 2026 was €363 Mil.
Hence, Minimed Group's Receivables Turnover for the
three
months ended in Apr. 2026 was 1.97.
Minimed Group (STU:B8S) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Minimed Group Receivables Turnover Related Terms
Minimed Group Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Minimed Group's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:B8S vs MMSI, NVST, STVN: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Minimed Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Minimed Group Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Minimed Group's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Minimed Group's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minimed Group (STU:B8S) has a Receivables Turnover of 1.97 as of Apr. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Minimed Group and its competitors. According to the industry distribution chart, Minimed Group ranks #600 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 73.9%.
Is Minimed Group's Receivables Turnover too high?
Minimed Group's current Receivables Turnover is 1.97. The Medical Devices & Instruments industry median Receivables Turnover is 5.60. Minimed Group's value of 1.97 is 64.8% below this industry median. Based on the distribution chart, Minimed Group ranks #600 out of 812 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Minimed Group has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Receivables Turnover compare to MMSI and NVST?
According to the Medical Devices & Instruments industry distribution chart, Minimed Group ranks #600 out of 812 companies for Receivables Turnover. This places Minimed Group in the lower half of its industry. The industry median Receivables Turnover is 5.60. Minimed Group's value of 1.97 is 64.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.60, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Minimed Group's current Receivables Turnover of 1.97 is 64.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Minimed Group and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Minimed Group's current Receivables Turnover is 1.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (STU:B8S) has a current Receivables Turnover of 1.97. The current Receivables Turnover is 1.97 and 64.8% below the Medical Devices & Instruments industry median of 5.60. Minimed Group's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Minimed Group (STU:B8S), the current Receivables Turnover is 1.97 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
20GF Score
Get the complete analysis for STU:B8S
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:B8S has been successfully added to your 
